USPTO serial 90732565
ORI BIOTECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 24, 2023
- Examiner
- GERMICK JR., EDWARD JOSEPH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ORI BIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Howard J Shire
Howard J Shire Troutman Pepper Locke LLP875 3rd AvenueNew York, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological preparations and biochemical preparations for industrial and scientific purposes, other than for medical purposes; chemical preparations and reagents for industrial and scientific purposes, other than for medical purposes; cell culture media for scientific use; biological tissue, namely, cultures, human tissue, animal tissue and cell cultures for industrial and scientific purposes; chemicals, biochemical and biological preparations for use in cell culturing for scientific and research use; cell growth media for cell culturing for scientific research use | ACTIVE | — |
| 005 | Chemical preparations, biochemical preparations and biological preparations for use in cell culturing, cell therapy and gene therapy; cell growth media for cell culturing for medical and clinical use, cell therapy and gene therapy | ACTIVE | — |
| 007 | Machine tools and power-operated tools, namely, electric and gas operated tube welders for use in the field of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment comprised of dispensation devices in the nature of devices for transferring matter into the bioreactor, namely, fluid dispensing machines for industrial use in the fields of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment comprised of cell harvesting devices in the nature of filtering machines and centrifuges for harvesting cells in the fields of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment comprised of cell selection devices, in the nature of a device for selecting and separating cells via magnetic separation and centrifugal separators in the fields of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment, comprised of machines for separating target materials from mixtures of materials in the fields of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment comprised of separating machines for chemical processing in the fields of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment comprised of media filling devices in the nature of injectors being parts of machines in the fields of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment comprised of cell filling devices in the nature of centrifugal pumps in the fields of cell culturing, cell therapy and gene therapy; industrial machines and manufacturing equipment comprised of agitation devices in the nature of agitators for circulating liquid media and centrifuges in the fields of cell culturing, cell therapy and gene therapy; replacement and structural parts and fittings for all the aforesaid; bellows, bags, vessels, bottles and containers for storing, containing, dispensing and extracting fluids, stem cells, cell cultures and cell culturing media being parts of industrial machines and manufacturing equipment; cassettes being parts of industrial bioreactors; disposable cassettes being parts of industrial bioreactors; replacement parts, including disposable replacement parts, for industrial manufacturing equipment in the fields of cell culturing, cell therapy and gene therapy, namely bioreactors for use in manufacturing biopharmaceuticals and custom medicine; connectors, namely, plastic pipe connectors being parts of industrial manufacturing apparatus in the fields of cell culturing, cell therapy and gene therapy; sterile connectors, namely, needle based connectors made of plastic being parts of industrial manufacturing apparatus in the fields of cell culturing, cell therapy and gene therapy; machines for adding and removing fluids to and from industrial manufacturing equipment for cell and gene therapies | ACTIVE | — |
| 009 | downloadable computer software and downloadable application software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment for cell culturing, cell therapy and gene therapy; downloadable computer software and downloadable application software for controlling, monitoring, programming and adjusting devices that control environmental conditions in a cell culturing container or bioreactor used for cell culturing, cell therapy and gene therapy; downloadable computer software and downloadable application software for logging, storing, and collecting data, in the fields of cell culturing, cell therapy and gene therapy; downloadable computer software and downloadable application software for monitoring patient health; downloadable computer software and downloadable application software for providing information on cell culturing, cell therapy and gene therapy; downloadable databases in the fields of cell culturing, cell therapy and gene therapy; computer hardware specifically adapted for use in the fields of cell culturing, cell therapy and gene therapy; electrical equipment for cell culturing, cell therapy and gene therapy, namely, cell culture chambers for the culturing and genetic modification of cells for research and commercial purposes; electrical equipment for cell culturing, cell therapy and gene therapy, namely, bioreactors, for the culturing and genetic modification of cells for research and commercial purposes; disposable structural and replacement parts for bioreactors; disposable scientific apparatus and instruments for cell culturing, cell therapy and gene therapy; sterile connectors, namely, needle based connectors made of plastic being parts of scientific apparatus for cell culture, cell therapy and gene therapy; bellows being parts of scientific apparatus and equipment for storing, dispensing or extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment; bellows being parts of scientific apparatus and equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment for cell culturing, cell therapy and gene therapy; bags being parts of scientific apparatus and equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment; bags being parts of scientific apparatus and equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment for cell culturing, cell therapy and gene therapy; flexible containers being parts of scientific apparatus and equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment; flexible containers being parts of scientific apparatus and equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment for cell culturing, cell therapy and gene therapy; compressible containers being parts of scientific apparatus and equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment; compressible containers being parts of scientific apparatus and equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment for cell culturing, cell therapy and gene therapy; vessels, bottles and containers being scientific equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment; vessels, bottles and containers being scientific equipment for storing, dispensing and extracting fluids, stem cells, cell cultures and cell culture media to and from scientific apparatus and equipment for cell culturing, cell therapy and gene therapy; incubators for cell culturing for laboratory use; incubators for maintaining cell cultures for laboratory use; bioreactor accessories for laboratory use, namely, bioreactor arrays, multiplexed bioreactor systems for cell culturing and aseptic filing and sealing machines for bioreactors; bioreactors for cell culturing; bioreactors for cell and gene therapy for laboratory use; scientific apparatus and instruments, namely, cell culturing hood, biological safety cabinets, water baths, and cell culture vessels for cell culturing, cell therapy and gene therapy; disposable bioreactors for cell culturing; scientific equipment for filling bioreactors, namely, bellows made out of thermoplastic elastomers, rubber, and plastic; incubators for growing cell cultures; structural and replacement parts and fittings for the aforementioned laboratory equipment, electrical equipment and scientific apparatus for use in the field of cell culture, cell therapy and gene therapy | ACTIVE | — |
| 010 | Industrial incubators for cell culturing, cell therapy and gene therapy for medical use; industrial incubators for maintaining cell cultures for medical use; incubators for cell culturing, cell therapy and gene therapy for medical use; incubators for maintaining cell cultures for medical use | ACTIVE | — |
| 017 | Flexible pipes, tubes and hoses, not of metal; plastic connectors for pipes, tubes and hoses; connectors of plastic, namely, plastic pipe connectors; sterile connectors of plastic, namely, plastic pipe connectors; plastic connectors and couplings for use with pipes, hosing, tubing used in apparatus for bioprocessing products and for use in cell culturing, cell therapy and gene therapy processing; packing and insulating materials; structural and replacements parts and fittings for flexible pipes, tubes and hoses, not of metal; structural and replacement parts and fittings for plastic connectors for pipes, tubes and hoses; structural and replacement parts and fittings for plastic pipe connectors; structural and replacement parts and fittings for sterile connectors of plastic, namely, plastic pipe connectors; structural and replacement parts and fittings for plastic connectors and couplings for use with pipes, hosing and tubing | ACTIVE | — |
| 020 | Racking for holding cell culturing, cell therapy and gene therapy manufacturing equipment; racking for bioreactors | ACTIVE | — |
| 037 | Installation, repair, maintenance and cleaning of scientific apparatus and equipment used for cell culturing, cell therapy and gene therapy; installation, repair, maintenance and cleaning of industrial machines and manufacturing equipment for cell culturing, cell therapy and gene therapy; installation, repair, maintenance and cleaning of bioreactors, filing machines for bioreactors, racking for bioreactors, bags for bioreactors, bellows for bioreactors, vessels for bioreactors, bottles and containers for bioreactors, incubators, cell culture hoods, bio-safety cabinets and water baths for laboratory use | ACTIVE | — |
| 040 | Custom manufacturing of cell culturing, cell therapy and gene therapy apparatus and equipment for others; custom manufacture of cell culturing, cell therapy and gene therapy apparatus and equipment for others, namely, bioreactors, filing machines for bioreactors, bags, bellows, vessels, bottles and containers, incubators, cell culture hood, bio-safety cabinets and water baths; custom manufacturing of industrial cell culturing, cell therapy and gene therapy; manufacturing equipment for others manufacturing services, namely, the manufacturing of cellular products based on human and animal cells in the nature of stem cells for medical purposes for others in the field of cell culturing, cell therapy and gene therapy; custom manufacture of therapeutic drugs, medicines, cell therapy products and gene therapy products for others; custom manufacture of cell culture products for others; custom manufacture of artificial meat and meat substitutes for others; rental and leasing of cell culture, cell therapy and gene therapy manufacturing apparatus | ACTIVE | — |
| 042 | Software as a service (SaaS) services featuring software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SaaS) services featuring software for monitoring environmental conditions within a cell culturing container and bioreactor and for controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions in the fields of cell culturing, cell therapy and gene therapy; providing temporary use of on-line non-downloadable computer software for monitoring environmental conditions within a cell culturing container and bioreactor and for controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions in the fields of cell culturing, cell therapy and gene therapy; platform as a service (PAAS) featuring computer software platforms for monitoring environmental conditions within a cell culturing container and bioreactor and for controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SAAS) services featuring software for collecting, storing, editing, analysing, processing and displaying data in the fields of cell culturing, cell therapy and gene therapy; providing temporary use of on-line non-downloadable computer software for collecting, storing, editing, analysing, processing and displaying data in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring software for collecting, storing, editing, analysing, processing and displaying data in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SaaS) services featuring software for monitoring patient health; Providing temporary use of on-line non-downloadable computer software for monitoring patient health; Platform as a service (PAAS) featuring computer software platforms for monitoring patient health; Software as a service (SaaS) services featuring software providing information in the fields of cell culturing, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for providing information in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for providing information in the fields of cell culturing, cell therapy and gene therapy; design and development of scientific equipment and apparatus in the fields of cell culturing, cell therapy and gene therapy; design and development of cell culture, cell therapy and gene therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; development of cell culture, cell therapy and gene therapy processes for others; rental and leasing of scientific apparatus and equipment for cell culturing, cell therapy and gene therapy; testing the functionality of apparatus and instruments in the nature of scientific apparatus and equipment used for cell culturing, cell therapy and gene therapy; testing the functionality of industrial machines and manufacturing equipment for cell culturing, cell therapy and gene therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 017
- Other trademarks in Class 020
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ORI BIOTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 16, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 16, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 16, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 11, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 11, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 11, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 11, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 24, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 24, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 8, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 8, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 19, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 21, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 21, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 21, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 21, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 13, 2023 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Jun 13, 2023 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Jun 13, 2023 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| May 12, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 11, 2023 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Apr 11, 2023 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Apr 11, 2023 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Mar 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 14, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 18, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 18, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 18, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 20, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2022 | ALIE | ASSIGNED TO LIE | — |
| Aug 15, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 28, 2021 | NWAP | NEW APPLICATION ENTERED | — |